Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation.

Lobo, P I; Spencer, C; Simmons, W D; Hagspiel, K D; Angle, J F; Deng, S; Markmann, J; Naji, A; Kirk, S E; Pruett, T; Brayman, K L

Lobo, P I; Spencer, C; Simmons, W D; Hagspiel, K D; Angle, J F; Deng, S; Markmann, J; Naji, A; Kirk, S E; Pruett, T; Brayman, K L.

Affiliation

Lobo PI; Department of Internal Medicine and Surgery, University of Virginia Health System, Charlottesville, VA 22908, USA. pil@virginia.edu

Transplant Proc ; 37(8): 3438-40, 2005 Oct.

Article in En | MEDLINE | ID: mdl-16298621

Subject(s)

Antibodies, Anti-Idiotypic/blood; Histocompatibility Antigens Class I/immunology; Islets of Langerhans Transplantation/immunology; Adult; B-Lymphocytes/immunology; Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 1/immunology; Diabetes Mellitus, Type 1/surgery; Female; Histocompatibility Testing; Humans; Insulin/therapeutic use; T-Lymphocytes/immunology; Transplantation, Homologous; Treatment Failure

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Histocompatibility Antigens Class I / Antibodies, Anti-Idiotypic / Islets of Langerhans Transplantation Limits: Adult / Female / Humans Language: En Journal: Transplant Proc Year: 2005 Document type: Article

Search on Google

XML

PubMed Links